The German Vaccination Commission has said that AstraZeneca’s COVID-19 vaccine should not be used on people aged 65 and over due to ‘insufficient data’ on its effectiveness.
The Standing Vaccination Commission said the survey, being developed with the University of Oxford, should only be used on people aged 18 to 64 “based on available data.”
“There are currently insufficient data to determine the efficacy of the vaccine for people aged 65 and over,” said the panel of scientific experts.
The recommendation follows confusion earlier this week about the efficacy of AstraZeneca’s jab in adults over 65.
Two German newspapers, citing government sources, said the shot was up to eight percent effective for the elderly – which according to the British company was “completely wrong”, German broadcaster Deutsch Welle reported on Tuesday.
“In November, we published data in The Lancet showing that older adults showed strong immune responses to the vaccine, with 100% of older adults generating a specific species of antibody after the second dose,” AstraZeneca’s spokesperson said.
The disturbing statistics were also refuted by the German Ministry of Health, which suggested that the leaks unite the figure of 8 percent.
“At first glance, two things appear to be confused in the reports: About 8% of the subjects in the AstraZeneca efficacy study were between 56 and 69 years old, and only 3 to 4% were older than 70 years old,” he said. a spokesman said.
“However, this does not lead to the effectiveness of only 8% in the elderly.”
The European Medicines Agency is expected to decide on Friday to approve the AstraZeneca vaccine.
With Post threads